SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-002413
Filing Date
2023-02-06
Accepted
2023-02-06 16:02:24
Documents
70
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-20221231.htm   iXBRL 10-Q 1085153
2 EX-3.1 exhibit31.htm EX-3.1 120107
3 EX-3.2 exhibit32.htm EX-3.2 145137
4 EX-10.1 exhibit101.htm EX-10.1 358643
5 EX-31.1 arwr-20221231xexx311.htm EX-31.1 9837
6 EX-31.2 arwr-20221231xexx312.htm EX-31.2 9835
7 EX-32.1 arwr-20221231xexx321.htm EX-32.1 4393
8 EX-32.2 arwr-20221231xexx322.htm EX-32.2 3987
  Complete submission text file 0001628280-23-002413.txt   6820005

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arwr-20221231.xsd EX-101.SCH 50101
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arwr-20221231_cal.xml EX-101.CAL 68078
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arwr-20221231_def.xml EX-101.DEF 250307
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arwr-20221231_lab.xml EX-101.LAB 561756
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arwr-20221231_pre.xml EX-101.PRE 400784
64 EXTRACTED XBRL INSTANCE DOCUMENT arwr-20221231_htm.xml XML 941266
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 23590648
SIC: 2834 Pharmaceutical Preparations